Further separating tumour samples in TCGA datasets by tumour mutation burden (TMB), it appeared that lower YTHDC1 expression coupled with lower TMB indicated worse overall survival (Figure S3C), as well as the same results were found in patients once lower YTHDC1 expression was coupled with lower TP53 level (Figure S4A,B). Here, TP53 is linked to neoplasm.